论文部分内容阅读
目的探讨脑脊液置换术治疗蛛网膜下腔出血性头痛的临床疗效及安全性。方法回顾性分析我院收治的70例蛛网膜下腔出血性头痛患者的临床资料,根据治疗方式分为治疗组和对照组各35例,治疗组采用脑脊液置换术治疗,对照组采用传统常规治疗,比较治疗后两组患者的临床疗效和不良反应发生情况。结果治疗组的脑膜刺激持续时间、头痛持续时间均显著低于对照组(P<0.05);治疗前两组患者的Glasgow评分无显著性差异(P>0.05),治疗后治疗组Glasgow评分显著高于对照组(P<0.05);治疗组患者并发症发生率显著低于对照组(P<0.05)。结论脑脊液置换术治疗蛛网膜下腔出血性头痛患者,能显著缩短患者的脑膜刺激持续时间和头痛持续时间,降低并发症的发生率,疗效确切,安全可靠。
Objective To investigate the clinical efficacy and safety of cerebrospinal fluid replacement for treatment of subarachnoid hemorrhagic headache. Methods The clinical data of 70 patients with subarachnoid hemorrhagic headache treated in our hospital were retrospectively analyzed. According to the treatment methods, 35 cases were divided into treatment group and control group. The treatment group was treated with cerebrospinal fluid replacement. The control group was treated with conventional treatment The clinical efficacy and adverse reactions of two groups were compared after treatment. Results The duration of meningeal stimulation and the duration of headache in the treatment group were significantly lower than those in the control group (P <0.05). There was no significant difference in Glasgow score between the two groups before treatment (P> 0.05), and the Glasgow score of the treatment group after treatment was significantly higher (P <0.05). The incidence of complications in the treatment group was significantly lower than that in the control group (P <0.05). Conclusion Cerebrospinal fluid replacement for patients with subarachnoid hemorrhage headache can significantly shorten the duration of meningeal stimulation and duration of headache, reduce the incidence of complications, the effect is accurate, safe and reliable.